Australia will begin rolling out the Novavax COVID-19 vaccine at select general practices, community pharmacies, and state clinics across the country for Australians aged 18 and over from Feb. 14, one week earlier than planned.
It is the first protein-based vaccine approved for Australians, allowing people who have allergies to certain ingredients used in approved vaccines or other issues to take an alternative option.
